Menu Search
Equities

Telesis Bio Inc

TBIO:NSQ

Telesis Bio Inc

Actions
  • Price (USD)3.09
  • Today's Change0.16 / 5.46%
  • Shares traded702.95k
  • 1 Year change-85.57%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Telesis Bio Inc has grown net income from a loss of -48.47m to a smaller loss of -47.72m despite relatively flat revenues.
Gross margin49.47%
Net profit margin-293.54%
Operating margin-287.97%
Return on assets-57.15%
Return on equity-1,357.97%
Return on investment-64.21%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Telesis Bio Inc fell by 28.85m. Cash Flow from Financing totalled 11.57m or 42.04% of revenues. In addition the company used 34.67m for operations while cash used for investing totalled 5.74m.
Cash flow per share-27.88
Price/Cash flow per share--
Book value per share5.61
Tangible book value per share3.22
More ▼

Balance sheet in USDView more

Telesis Bio Inc has a Debt to Total Capital ratio of 35.60%, little changed from the previous year's 35.50%.
Current ratio1.89
Quick ratio1.72
Total debt/total equity0.5529
Total debt/total capital0.356
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.